Biofrontera Inc. Income Statement

Income Statement Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 50.00M24.10M28.67M34.07M37.32M
Cost of Revenue 0.52M17.90M17.44M18.61M
Gross Profit 23.58M10.77M16.63M18.71M
Operating items
Research & Development 0.08M2.09M
Selling, General & Administrative 36.51M35.14M18.49M16.28M
Restructuring Costs 0.75M
Other Operating Expenses 12.04M12.12M38.18M36.16M
Operating Expenses 49.30M47.26M56.75M54.53M
Operating Income -25.20M-18.58M-22.68M-17.21M
EBIT -25.20M-18.58M-22.68M-17.21M
Non-operating items
Non Operating Investment Income 1.75M-7.42M-0.01M
Interest & Investment Income -0.47M-2.04M
Other Non Operating Income 0.69M0.03M-0.07M-0.32M
Non Operating Income -12.46M17.97M2.56M-0.53M
Net income details
EBT -37.66M-0.61M-20.12M-17.74M
Tax Provisions 0.06M0.03M0.01M0.02M
Profit After Tax -37.71M-0.64M-20.13M-17.76M
Income from Continuing Operations -37.71M-0.64M-20.13M-17.76M
Consolidated Net Income -37.71M-0.64M-20.13M-17.76M
Income towards Parent Company -37.71M-0.64M-20.13M-17.76M
Net Income towards Common Stockholders -37.71M-0.64M-20.13M-17.76M
Additional items
EPS (Basic) -479.48-4.28-0.61-13.02-3.22
EPS (Weighted Average and Diluted) -0.61-13.02-3.22
Shares Outstanding (Weighted Average) 0.75M1.33M1.52M7.75M
Shares Outstanding (Diluted Average) 1.06M1.55M5.52M
EBITDA -25.20M-18.58M-22.68M-17.21M
Interest Expenses 0.22M2.11M